Global Oligonucleotide Synthesis Market to Grow at 11.1% During 2024-2032, Impelled by the Increasing COVID-19 Cases

May 10, 2021 | Healthcare

According to the latest report by IMARC Group, titled “Oligonucleotide Synthesis Market Report by Product (Synthesized Oligonucleotide Products, Reagents, Equipment, Services), Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization (FISH), Antisense Oligonucleotides, and Others), End Use (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Academic Research Institutes), and Region 2024-2032,” the global oligonucleotide synthesis market reached a value of US$ 3.0 Billion in 2023. Oligonucleotide synthesis is the chemical amalgam of short fragments of the nucleic acids produced through enzymatic chemistry and genetic engineering. The technique is beneficial in current laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis provides rapid and inexpensive access to custom-made oligonucleotides for various end users through Deoxyribonucleic acid (DNA) synthesizers for self-consumption. It is used to develop primers and probes in recombinant DNA technologies to develop monoclonal antibodies. Oligonucleotide synthesis is also utilized in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening.

Global Oligonucleotide Synthesis Market Trends:

The rapid outbreak of coronavirus disease (COVID-19) and an imminent need for a potential treatment represent one of the key factors driving the market growth. This is further facilitated by the ongoing development efforts of mRNA and DNA vaccines as a cure to the disease. The market is also driven by the increasing requirement to develop novel diagnostic techniques and effective therapies to treat chronic ailments. The rising geriatric population and the demand for personalized medicines are acting as another major growth-inducing factor. In addition to this, advances in purification and quality control technologies are enabling a significant reduction in the overall cost of oligonucleotide techniques while substantially increasing the quality and yield. This, in turn, is promoting the application of oligonucleotide synthesis in a range of available modifications, which is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and the introduction of various oligonucleotide-based therapies to treat viral infections, rare genetic disorders, and neuromuscular conditions, are contributing to the market growth. Looking forward, the market is expected to grow at a CAGR of 11.1% during 2024-2032.

Market Summary:

  • On the basis of the product, the market has been divided into synthesized oligonucleotide products, reagents, equipment and services.
  • Based on end use, the market has been classified into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories and academic research institutes.
  • Based on the application, the market has been classified into PCR primers, PCR assays and panels, sequencing, DNA microarrays, Fluorescence in-situ hybridization (FISH), antisense oligonucleotides and others.
  • On a regional basis, the market has been spread across North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Application, End Use, Region
Region Covered North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Countries Covered United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Oligonucleotide Synthesis Market to Grow at 11.1% During 2024-2032, Impelled by the Increasing COVID-19 Cases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More